===== MDA5 =====
  * **Kyoto University group**
    * famous for [[https://doi.org/10.1002/art.41105 | pred + tacro + CYC for RP-ILD a/w MDA5]]
    * important names:
      * Ran Nakashima
      * Tsuneyo Mimori 
  * **Chiba University**
    * [[https://doi.org/10.1136/rmdopen-2022-002795 | Tofacitinib for refractory MDA5]]
====== FAPi Scans ======

  * [[https://doi.org/10.1148/radiol.220749 | Review: FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease]]
  * [[https://doi.org/10.1038/s44303-024-00053-z | Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)]]
  * [[https://doi.org/10.1007/s00259-023-06564-y | Initial results with [$^{18}$F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis]]
  * [[https://doi.org/10.2967/jnumed.121.261925 | Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study]]
  * [[https://doi.org/10.1016/s2665-9913(20)30421-5 | FAPI in SSC-ILD]]
  * [[https://doi.org/10.1164/rccm.202110-2414oc | Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases]]

====== SOMA Scans ======
[[https://somalogic.com/somascan-platform/ | SomaScan Site]]

allows measurement of 11,000 proteins from 55 $\mu L$ sample


  * [[https://doi.org/10.1164/rccm.202109-2106OC | SomaScan in PAH]]
  * [[https://doi.org/10.1101/2024.07.11.24310161]]
  * [[http://doi.org/10.1021/acs.jproteome.4c00411]]
  * [[https://doi.org/10.1038/s41586-023-06563-x | Nature, Large-scale plasma proteomics comparisons through genetics and disease associations]]


====== SEER proteomics ======
  * [[https://doi.org/10.1101/2024.01.03.24300798 | seminal paper]]
  * [[https://doi.org/10.1038/s41467-024-45233-y | Nat Com, nanoparticle enrichment mass-spec proteomics]]